Global Biochip Markets: Microarrays and Lab-on-a-Chip

Report Code: BIO049G

Publish Date: Jun 2025

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

30% Off

Limited Period Offer

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Report Includes

  • 76 data tables and 56 additional tables
  • An analysis of the current and future global markets for biochip diagnostic products and technologies
  • Analyses of global market trends, with historic revenue data from 2021 to 2024, and projected CAGRs through 2029
  • Estimates of the size of and revenue prospects for the global biochip market, along with a market share analysis by product type, technology, application, end-user vertical, and region
  • Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macro-economic factors
  • A look at the major commercial biochip products and the future potential of each key market segment, emerging technologies, clinical trials, and other new developments
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading biotech companies
  • Analysis of the industry structure, including companies’ market shares, strategic alliances, M&A activity, venture fundings and investment outlook
  • Company profiles of major players within the industry, including Abbott, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., and BioMérieux

Report Scope

This report provides an overview of the global biochip market and analyzes market trends. The report includes global revenue ($ million) for the base year 2023 and estimated data for the forecast period 2024 through 2029. The market is segmented based on product type, technology, application, end user industry and region. The regions covered in this study include North America, Europe, Asia-Pacific and Rest of the World (South America, the Middle East and Africa), focusing on major countries in these regions.

The report focuses on the significant trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the ranking and shares of key companies in the global biochip market. There is also a dedicated section on company profiles that provides details about leading companies in the market.

The company profiles offer detailed information about business segments, financials, product portfolios and recent developments. By geographical region, the market has been segregated into North America, Europe, Asia-Pacific and the Rest of World, which includes the Middle East, Africa and South America. The North American region covers the U.S., Canada and Mexico. Europe examines Germany, the U.K., Italy, France, Spain and the Rest of Europe. Asia-Pacific encompasses China, Japan, India, Australia, South Korea and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, with estimates for 2024 and a forecast for 2025 through 2029.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $14.4 billion
Market size forecast $27.8 billion
Growth rate CAGR of 11.6% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered Product, Technology, Application, End User
Regions covered North America, Europe, Asia-Pacific, Rest of the World
Countries covered U.S., Canada, Mexico, U.K., France, Germany, Italy, Spain, China, Japan, India, South Korea, Australia, South America, Middle East, Africa
Key Market Drivers
  • Rising Demand for Point-of-Care Diagnostics
  • Increasing Investment and Funding in Biochip and Microarray Research Activities
  • Increasing Prevalence of Cancer Generating Demand for Personalized Treatments
Companies studied
THERMO FISHER SCIENTIFIC INC.ABBOTT
AGILENT TECHNOLOGIES INC.BIOMÉRIEUX
BIO-RAD LABORATORIES INC.F. HOFFMANN-LA ROCHE LTD.
IBIOCHIPSILLUMINA INC.
LI-COR BIOTECH LLC.MICRONIT B.V.
NUTCRACKER THERAPEUTICS INC.QIAGEN
RANDOX LABORATORIES LTD.REVVITY
STANDARD BIOTOOLS
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The global market for biochip was valued at $14.4 billion in 2023 and is projected to reach $27.8 billion by the end of 2029.
The rising demand for point-of-care diagnostics, increasing investment and funding in biochip and microarrays research activities, and growing prevalence of cancer generating demand for personalized treatments were reviewed to understand the market dynamics and trends for forecasting the market size.
The market scope in this report is segmented based on product type, technology, application, end-user industry, and region. The market is segmented into microarrays (array-based biochips), microfluidic biochips (lab-on-a-chip), biochip equipment & software, and biochip consumables & kits based on product type. Based on technology, the market is segmented into microarrays technology and microfluidics technology. The market is categorized as genomics, proteomics, disease diagnostics, and drug discovery and development based on application. Based on end-users, the market is segmented into academic and research institutes, biopharmaceutical companies, and hospitals and diagnostic centers.
Biochip Equipment & Software will dominate the biochip market.
The North American biochip market was valued at $6.8 billion in 2023 and is estimated to reach $13.2 billion in 2029, at a CAGR of 11.8% during the forecast period.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Mariana Kuznietsova, a Life Science Consultant at BCC Research, has 8 years of experience in both academic and industry research developing biochemical and biotechnological applications and laboratory services. She also has a strong background in laboratory equipment trading services covering technical support, complex lab solutions to meet demands of laboratories from a range of areas, such as Academia, Agriculture, Pharma, and Food and Beverage. Mariana holds a Ph.D. in Biochemistry from the Taras Shevchenko National University of Kyiv, Ukraine.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Biochip Markets: Microarrays and Lab-on-a-Chip136Free
Chapter- 1: Executive Summary4Free
Chapter- 2: Market Overview3Free
Chapter- 3: Market Dynamics6Free
Chapter- 4: Regulatory Landscape4Free
Chapter- 5: Emerging Technologies and Developments2Free
Chapter- 6: Market Segmentation Analysis57Free
Chapter- 7: Competitive Intelligence6Free
Chapter- 8: Sustainability in the Biochip Market: An ESG Perspective9Free
Chapter- 9: Appendix45Free

Related Reports

U.S. Fertility Clinics Market

Published - Jul 2023 | Publisher - BCC Publishing | Code - HLC209B

The U.S. market for fertility clinic services is estimated to increase from $8.9 billion in 2023 to reach $16.8 billion by 2028, at a compound annual growth rate (CAGR) of 13.6% from 2023 through 2028.

Breast Cancer Diagnostic and Drug Technologies: Global Markets

Published - Dec 2019 | Publisher - BCC Publishing | Code - HLC106D

The global breast cancer diagnostic and drug market should reach $28.2 billion by 2024 from $20.9 billion in 2019 at a compound annual growth rate (CAGR) of 6.2% for the forecast period of 2019 to 2024.

Drugs for Infertility: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Research Reference Staff | Code - PHM194A

The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 132

  • Summary Table: Global Biochip Market, by Product Type, Through 2029
  • Table 1: Molecular Biology Technologies for Microarray Approaches
  • Table 2: Global Biochip Market, by Product, Through 2029
  • Table 3: Global Market for Microarrays , by Region, Through 2029($ Millions)
  • Table 4: Global Market for Microarrays (Array-Based Biochips), by Product, Through 2029
  • Table 5: Global Market for DNA Microarrays, by Region, Through 2029
  • Table 6: Commercially Available Protein Microarrays
  • Table 7: Global Market for Protein Microarrays, by Region, Through 2029
  • Table 8: Global Market for Peptide/Tissue/Other Specialty Microarrays, by Region, Through 2029
  • Table 9: Global Market for Microfluidic Biochips (Lab-on-a-Chip), by Region, Through 2029
  • Table 10: Global Market for Microfluidic Biochips (Lab-on-a-Chip), by Product, Through 2029
Sample Report

Recent Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Human Microbiome-based Drugs and Diagnostics: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO151B

The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.

Global Microbiome Sequencing Market

Published - May 2025 | Publisher - BCC Publishing | Code - BIO183B

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Top Trending Reports

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Published - Apr-2016| Analyst - Jon Evans| Code - BIO049F

Report Highlights

The global market for biochip products reached nearly $3.9 billion in 2014. This market is projected to grow from $4.7 billion in 2015 to $18.4 billion in 2020, representing a compound annual growth rate (CAGR) of 31.6% between 2015 and 2020.

Report Includes

  • An overview of the global market for current and emerging biochip technologies.
  • Analyses of global market trends, with data from 2014, 2015, and projections of CAGRs through 2020.
  • Characterizations of biochip markets by type (DNA microarray, protein microarray, emerging microarray, and lab-on-a-chip); by function (gene expression, genotyping, micro-RNA, epigenetic, sequence capture); and by end-user (research-and-development tools, drug discovery and development, diagnostics, sequencing, and applied).
  • A focused study on the market for biochip-based diagnostics products, a major future segment for biochips.
  • Discussion of the main commercial biochip technologies and the commercial potential of the key market segments.
  • Examination of the factors that influence the market, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, and customer needs.
  • Patent analysis.
  • Profiles of major players in the industry.
Published - Oct-2013| Analyst - John Bergin| Code - BIO049E

Report Highlights

The global biochip products market reached $3.3 billion in 2012. This market is expected to grow to nearly $3.9 billion in 2013 and $14.4 billion in 2018 at a compound annual growth rate (CAGR) of 30% for the five-year period 2013 to 2018.

Report Includes

  • An overview of the global market for current and emerging biochip technologies and products
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • Characterizations of biochip markets by type (DNA microarray, protein microarray, emerging microarray, and lab-on-a-chip); by function (gene expression, genotyping, micro-RNA, epigenetic, sequence capture); and by end-user (research-and-development tools, drug discovery and development, diagnostics, sequencing, and applied)
  • A focused study on the market for biochip-based diagnostics products, a major future segment for biochips
  • Discussion of the main commercial biochip technologies and the commercial potential of the key market segments
  • Examination of the factors that influence the market, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, and customer needs
  • Patent analysis
  • Comprehensive company profiles of major players.

Published - Aug-2011| Analyst - John Bergin| Code - BIO049D

Report Highlights

The global value of the overall biochips market, by end use was $3.5 billion in the year 2010. The size of the biochips market will increase from $3.9 billion in 2011 to nearly $9.6 billion by 2016, a compound annual growth rate (CAGR) of 19.5%.

Published - Jan-2010| Analyst - John Bergin| Code - BIO049C

Report Highlights

  • The total market for biochips was $2.4 billion in 2008 which increased to $2.6 billion in 2009. This is expected to grow at compound annual growth rate (CAGR) of 17.7% to reach $5.9 billion by 2014
  • The DNA microarrays market was nearly $1.2 billion in 2008; this further increased to $1.3 billion in 2009, this projected to reach $2.7 billion in 2014, for a 5-year CAGR of 15.2%.
  • Sales in the LOAC market amounted to $755 million in 2008 which increased to $817 million in 2009. This is projected to increase to $2.1 billion in 2014, for a 5-year CAGR of 20.9%.
Published - Sep-2007| Analyst - John Bergin| Code - BIO049B

Report Highlights

  • The global market for biochips increased from $1,637.5 million in 2006 to an estimated $2,115.6 million by the end of 2008. It should reach $3,840.7 million in 2013, a compound annual growth rate (CAGR) of 12.7%.
  • DNA microarrays dominate the market today, expected to be worth $947.3 million in 2007, followed by lab-on-a-chip (LOAC), expected to be worth $625.8 million in 2007.
  • The largest market segment for biochips is in drug discovery and development.
Published - Jan-2004| Analyst - Sam Brauer| Code - BIO049A

Report Highlights

  • The total market for DNA microarrays and materials totaled $544.4 million in 2002. Rising at an AAGR (average annual growth rate) of 13.4%, this market is expected to just exceed $1 billion in 2007.
  • Microarrays themselves make up the bulk of the market and sales are expected to rise at an AAGR of 11.7% through 2007 to reach $744 million.
  • Materials sales will rise faster due to increasing complexity, reaching $275 million in 2007 at an AAGR of 18.8%.
  • Although DNA microarrays are entering a period of more modest growth (growth was at 30%/year just a few years ago), there are some dramatic changes taking place in the types of microarrays being produced.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Biochip Markets: Microarrays and Lab-on-a-Chip
Sample Report